Nisa Investment Advisors’s Spyre Therapeutics SYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$8.17K Buy
546
+362
+197% +$5.42K ﹤0.01% 2340
2025
Q1
$2.97K Buy
184
+64
+53% +$1.03K ﹤0.01% 2370
2024
Q4
$2.79K Buy
120
+9
+8% +$210 ﹤0.01% 2399
2024
Q3
$3.27K Buy
+111
New +$3.27K ﹤0.01% 2309
2022
Q1
Sell
-528
Closed -$57K 2398
2021
Q4
$57K Buy
+528
New +$57K ﹤0.01% 1697